Investing.com - AstraZeneca (NASDAQ:AZN) reported on Thursday fourth quarter earnings that beat analysts' forecasts and revenue that topped expectations.
AstraZeneca announced earnings per share of $1.67 on revenue of $12.01B. Analysts polled by Investing.com anticipated EPS of $1.54 on revenue of $11B.
AstraZeneca shares are up 3% from the beginning of the year, still down 9.44% from its 52 week high of $9,523.00 set on November 5, 2021. They are outperforming the Dow Jones which is down 1.57% from the start of the year.
AstraZeneca shares gained 3.11% in intra-day trade following the report.
AstraZeneca follows other major Healthcare sector earnings this month
AstraZeneca's report follows an earnings beat by GlaxoSmithKline on Wednesday, who reported EPS of $0.256 on revenue of $9.53B, compared to forecasts EPS of $0.2417 on revenue of $9.44B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar